LifeStance Health (LFST) Depreciation & Amortization (CF) (2020 - 2026)

LifeStance Health (LFST) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $13.3 million in Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $13.3 million, down 3.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $54.3 million (down 12.6% YoY), and the FY2025 annual result was $54.8 million, down 22.83% from the prior year.
• Depreciation & Amortization (CF) eased to $13.3 million in Q1 2026 per LFST's latest filing, from $13.4 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $22.6 million in Q1 2024 and troughed at $13.3 million in Q1 2026.
• A 5-year average of $17.0 million and a median of $16.7 million in 2022 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) soared 31.07% in 2022, then plunged 39.04% in 2025.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $18.9 million in 2022, then rose by 17.63% to $22.2 million in 2023, then sank by 33.96% to $14.7 million in 2024, then dropped by 8.43% to $13.4 million in 2025, then retreated by 0.86% to $13.3 million in 2026.
• Business Quant data shows LFST's Depreciation & Amortization (CF) at $13.3 million in Q1 2026, $13.4 million in Q4 2025, and $13.6 million in Q3 2025.